Summary: ACCU Reference Medical Laboratory launched new molecular PCR panels for diagnosing tick-borne diseases, aiming to improve accuracy, speed, and comprehensiveness in detecting these infections for better patient outcomes.
Takeaways:
- Advanced Diagnostic Precision: The new PCR panels offer enhanced sensitivity and specificity, allowing for accurate detection of multiple tick-borne pathogens, even at early infection stages.
- Swift Results for Prompt Treatment: With rapid turnaround times, these panels enable quicker clinical decisions, facilitating timely and appropriate treatment interventions.
- Comprehensive and Efficient Testing: The panels cover a broad spectrum of tick-borne diseases, reducing the need for multiple tests and streamlining the diagnostic process for healthcare providers and patients.
ACCU Reference Medical Laboratory announced the implementation and availability of new molecular PCR panels for the diagnosis of tick-borne diseases, which aims to enhance the accuracy, speed, and comprehensiveness of diagnosing these diseases for better patient outcomes.
New Tick-Borne Disease Diagnostics
Tick-borne diseases are a growing concern, nationwide, with cases on the rise, due to increasing tick populations and expanding geographic ranges. These diseases, including Lyme Disease, Anaplasmosis, Babesiosis, Ehrlichiosis, and Rickettsia Species can present with non-specific symptoms that complicate diagnosis. Early and accurate detection is crucial for effective treatment and prevention of severe complications.
The new molecular PCR panels introduced by ACCU Reference Medical Lab offer a highly sensitive and specific method for detecting various tick-borne pathogens. This cutting-edge technology allows for the simultaneous identification of multiple pathogens in a single test, providing a comprehensive diagnostic solution.
Benefits of the New PCR Panels for Diagnosis of Tick-Borne Pathogens
Enhanced Sensitivity and Specificity: The molecular PCR panels are designed to detect even low levels of pathogen DNA, ensuring accurate diagnosis even in early stages of infection.
Rapid Turnaround Time: Results are available within hours, allowing for prompt clinical decision-making and initiation of appropriate treatment.
Comprehensive Detection: The panels cover a broad range of tick-borne pathogens, reducing the need for multiple tests and improving diagnostic efficiency.
Minimally Invasive: The tests require only a small blood sample, making the process easier and more comfortable for patients.
“We are thrilled to bring this advanced diagnostic tool to our healthcare providers and patients,” says Julian Arce, MD, BS, laboratory director of ACCU Reference Medical Lab. “Our new molecular PCR panels represent a significant leap forward in the fight against tick-borne diseases. By providing faster and more accurate diagnoses, we aim to improve patient outcomes and contribute to public health efforts in managing these complex infections.”
About ACCU Reference Medical Lab
ACCU Reference Medical Lab is a multi-specialty reference laboratory dedicated to providing comprehensive diagnostic services, nationwide. With a focus on accuracy, reliability, and innovation, the laboratory offers a wide range of tests to support healthcare providers in delivering optimal patient care.
